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Abstract
Background: Medication errors cause a large number of adverse drug events with negative patient health
outcomes and are a major public-health burden contributing to 18.7–56 % of all adverse drug events among
hospitalized patients. The aim of this study was to assess the incidence and determinants of medication errors and
adverse drug events among hospitalized children.
Methods: A prospective observational study was conducted among hospitalized children in the pediatrics ward of
Nekemte Referral Hospital from February 24 to March 28, 2014. Data were collected by using checklist guided
observation and review of medication order sheets, medication administration records, and other medical charts of
the patients. To identify the independent predictors of medication errors and adverse drug events, backward
logistic regression analysis was used. Statistical significance was considered at p-value <0.05.
Results: Out of 233 patients who were included in the study, 175 (75.1 %) of patients were exposed to medication
errors. From the 1,115 medication orders reviewed, 513 (46.0 %) medication errors, 75 (6.7 %) potential adverse drug
events and 17 (1.5 %) actual adverse drug events were identified. Of the 17 adverse drug events, eight (47.0 %) were
preventable while nine (53.0 %) were not. Most medication errors were dosing errors (118; 23.0 %), followed by wrong
drug (109; 21.2 %) and wrong time of administration (79; 15.4 %). On multivariable logistic regression analysis, length of
hospital stay of≥ 5 days (AOR = 4.2, 95 % CI = 1.7-10.4, p = 0.002), and number of medication of 4–6 (AOR = 4.9, 95 %
CI = 2.3-10.3, p < 0.001) and number of medication of ≥7 (AOR = 10.4, 95 % CI = 3.0-35.9, p < 0.001) were independent
predictors of medication errors; and length of hospital stay of≥ 5 days (AOR = 3.5, 95 % CI = 1.2-10.1, p = 0.023) and
number of disease conditions =2 (AOR = 4.6, 95 % CI = 1.4-15.1, p = 0.014) were independent predictors of adverse
drug events.
Conclusion: Medication errors and adverse drug events are common on the pediatrics ward of Nekemte Referral
Hospital. In particular, children with multiple medications and longer hospital stays, and those with co-morbidities and
longer hospital stays, were at greater risk for medication errors and adverse drug events, respectively.
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Background
All adverse drug events (ADEs), adverse drug reactions
(ADRs), and medication errors (MEs) fall under the
umbrella of medication misadventures. An ADE refers
to any injury caused by a medicine [1]. The term ADE
includes harm caused by the drug (adverse drug
reactions and overdoses) and harm from the use of the
drug (including dose reductions and discontinuations of
drug therapy). An ADE refers to all ADRs, including
allergic or idiosyncratic reactions, as well as MEs that re-
sult in harm to a patient. ADRs refer to any unexpected,
unintended, undesired, or excessive response to a medi-
cine; it is harm directly caused by the drug at normal
doses, during normal use [2]. A ME is any preventable
event that has the potential to lead to inappropriate
medication use or patient harm; many occur during
prescribing, transcribing, dispensing, administering,
adherence, or monitoring a drug [1, 2].
If the ME has resulted in actual patient harm, it is
categorized as an ADE. An ADE can be either prevent-
able or non-preventable. A potential ADE is a ME that
has the potential to harm a patient but which does not
actually cause any harm (near-miss) [3]. It is further cat-
egorized as intercepted or non-intercepted. An inter-
cepted potential ADE is a drug order that is intercepted
before it reaches the patient, whereas a non-intercepted
potential ADE has reached the patient but does not
cause injury because the patient has sufficient physio-
logical reserves [3].
The top 10 causes of pediatric errors for the 2-year
period of the calendar year 1999 to 2000 reported in the
United States Pharmacopeia (USP) were the following:
performance deficit, procedure or protocol not followed,
miscommunication, inaccurate or omitted transcription,
improper documentation, drug distribution system error,
knowledge deficit, calculation error, computer entry
error, and lack of system safeguards [4].
Children are at higher risk for MEs and ADEs for nu-
merous reasons [5]. The weight of a young infant
changes rapidly and dosage adjustments may be required
as they grow. Frequently there is the lack of an appropri-
ate dosage form for the pediatric patient and adult for-
mulations must be diluted or reformulated for use in
children. Absorption, transport, metabolism, and excre-
tion may vary by age [6]. In addition, information or
Food and Drug Admiration (FDA) labeling regarding
dosing, safety, efficacy, and clinical use in pediatrics is
not available or is insufficient, therefore, off-label usage
occurs. Without such prescribing, effective therapy
would be denied to many children [5, 6]. MEs cause a
large number of ADEs with negative patient health out-
comes each year and are major public-health burdens
representing 18.7–56 % of all ADEs among hospitalized
patients [7].
In Ethiopia, a study done in the pediatric ward of Jimma
University Specialized Hospital (JUSH) showed that the
prevalence of medication administration errors was 89.9 %
[8]. Similarly another study from the same setting showed
that MEs had an incidence of 55.4 per 100 admissions and
ADEs had an incidence of 9.2 per 100 admissions (Chanie
et al. 2011, unpublished work).
To the best of our knowledge there are little or no
published data on MEs and ADEs among hospitalized
children in Ethiopia. This study fills the information gap
through assessing the incidence and type of MEs and
ADEs; and identifying the factors associated with MEs
and ADEs in hospitalized children.
Methods
Study setting and period
The research was conducted in the pediatrics ward of
Nekemte Referral Hospital, which is found in Nekemte
town, West Ethiopia. Nekemte Referral Hospital has
clinical divisions such as surgery, gynecology and obstet-
rics, pediatrics, internal medicine, psychiatry and derma-
tology. The pediatrics ward contains 47 beds and there
are two pediatricians and two general practitioners
working in the ward. The study was conducted between
February 24 to March 28, 2014.
Study design
Prospective observational study was conducted among
hospitalized children.
Study population
All children hospitalized on the pediatrics ward of
Nekemte Referral Hospital during study period taking at
least one medication for treatment or prophylaxis and
who stayed for at least 24 h in the ward were included
in the study.
Data collection process and data quality assurance
Data were collected by using different approaches. These
included:
 Daily chart review for all admissions until discharge/
transfer/death: by visiting the study participants
daily and reviewing procedure notes, physician
progress notes, pertinent laboratory reports,
physician orders, medication administration records,
nursing/multidisciplinary progress notes and
discharge summary.
 Attending multidisciplinary ward rounds: the principal
investigator attended clinical rounds and asked for the
presence of any alerts for MEs and ADEs.
 Interview of children and/or parents/caregivers,
when further information or clarification of
information was required.
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 All pediatrics ward staff were informed about the
study and invited to take part by submitting
voluntary reports of any events in the medication
deliver process that they noted during their daily
activities.
MEs and ADEs was classified in accordance of
standard books like, “Pocket book of pediatric Hospital
care: Ethiopia” as a reference [9], for additional informa-
tion World Health Organization (WHO) pocket book of
hospital care for children [10], Lexi-Comp’s Pediatric
Dosage Handbook [11] and British National Formulary
(BNF) for children [12] were used. In addition, actual
occurrences of events for reliability that was originally
reviewed by principal investigator, severity and prevent-
ability was evaluated by a panel of two health profes-
sionals (one pediatrician and one clinical pharmacist),
who independently categorized the events using a
prepared reviewer form. When disagreement affected
classification of an event, the reviewers reach consensus
through discussion.
Data were collected by using a checklist which was
adapted from a checklist prepared for the California
Health Care Foundation for addressing MEs in hospitals
[13], during hospitalization by visiting the wards daily
and examining all relevant patient records. The pediatric
trigger toolkit was used for efficient chart review and
identification of adverse drug events [14]. The severity
of ADE was reported by using the detailed scale pub-
lished by the National Coordinating Council for Medica-
tion Error Reduction and Prevention (NCC MERP) [14].
The Naranjo ADR probability scale was also used to es-
tablish the likelihood of ADR occurrence [15].
Data analysis and interpretation
After data collection, data were entered into the Statis-
tical Package for the Social Sciences (SPSS) version 16
for analysis. Odds ratio with 95 % confidence interval,
along with binary and multiple logistic regression was
used to assess the significance and strength of associ-
ation. All factors with a p-value <0.25 in the bivariable
logistic regression analysis were further entered into the
multivariable model to control confounding effects. In
multiple logistic regression a p-value <0.05 was used as
statistically significant. Rates of MEs and ADEs were
reported per 100 orders, 100 admissions, and 100
patient-days [14].
Ethical considerations
Ethical clearance was obtained from the Ethical Review
Committee of Jimma University, College of Public
Health and Medical Sciences. This committee wrote a
formal letter of permission dated the 12th February
2014; reference number “RPGO/295/2014” to Nekemte
Referral Hospital to seek its cooperation and access to
the data. Patient’s written informed consent was ob-
tained after explaining about the purpose and proce-
dures of the study. When the child was too young to
provide written informed consent, it was obtained from
parents/caregivers. In addition all the responses were
kept confidential. For those patients in whom serious
MEs and ADEs were detected, these were brought to the
attention of the appropriate staff immediately together
with strategies to manage them.
Definitions of terms
For the purpose of this study the following definitions
were adopted with regards to MEs and ADEs:
Omission error: The failure to administer an ordered dose
to a patient before the next scheduled dose, if any [16].
Wrong time error: Administration of medication
outside a predefined time interval from its scheduled
administration time (if there is greater than 1 h
difference between the ordered time and the time the
medication is administered) [16, 17].
Wrong dosage-form error: Administration to the pa-
tient of a drug product in a different dosage form than
ordered by the prescriber [16].
Deteriorated drug error: Administration of a drug that
has expired or for which the physical or chemical
dosage-form integrity has been compromised [16].
Wrong dose error: Administration to the patient of a
dose that is greater than or less than the amount
ordered by the prescriber or administration of duplicate
doses to the patient, i.e., one or more dosage units in
addition to those that were ordered [16].
Non-adherence: Inappropriate patient behavior regarding
adherence to a prescribed medication regimen [16].
Wrong route: Includes order written for wrong route,
transcribed for wrong route and medication
administered to a patient using a different route than
ordered [17].
Lack of knowledge of the medication: Inadequate
knowledge of indications for use, available dosage forms,
appropriate doses, routes and compatibilities [18].
Lack of information about the patient: Nurse, physician
or pharmacist was unaware of an important aspect of
the patient’s condition [18].
Preventable: Events where a breach of standard
professional behavior or technique was identified, or
where necessary precautions were not taken, or where
the event was preventable by modification of behavior,
technique or care [19].
Non-Preventable: Events where no obvious breach of
standard professional behavior or technique occurred,
and where necessary precautions were taken, and
where no clearly known alteration in method or care
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exists to prevent the event. Examples of non-
preventable ADEs include the following: Dermatological
reactions from unknown allergens; known side effects
without identified mitigation strategies; Known side
effects that are accepted for the benefit of the drug (i.e.
nausea with chemo-therapy) [19].
Severity of MEs and ADEs were reported by using the de-
tailed scale published by the NCC MERP, which is catego-
rized through A to I. Categories A through D of the NCC
MERP Index are relevant to MEs and Categories E through
I of the NCC MERP Index are relevant to ADEs [14]:
Category A: Circumstances or events that have the
capacity to cause error.
Category B: An error occurred but the error did not
reach the patient.
Category C: An error occurred that reached the patient
but did not cause patient harm.
Category D: An error occurred that reached the patient
and required monitoring or intervention to confirm
that it resulted in no harm to the patient and/or
required intervention to preclude harm.
Category E: An error occurred that resulted in the
need for treatment or intervention and caused
temporary patient harm.
Category F: An error occurred that resulted in initial or
prolonged hospitalization and caused temporary harm.
Category G: An error occurred that resulted in
permanent patient harm.
Category H: An error occurred that resulted in near-
death event (e.g. cardiac arrest).
Category I: An error occurred that resulted in patient
death.
Results
The study included a total of 233 patients, cumulative
hospital stay of 999 patient-days, and 1,115 medication or-
ders. More than half of the patients, 149 (63.9 %) were
males. Thirty six (15.5 %) of the cases were neonates, 75
(32.2 %) infants, 43 (18.5 %) toddlers, 31 (13.3 %)
preschoolers, 29 (12.4 %) school-aged children, and 19
(8.2 %) adolescents. Among 233 patients, 162 (69.5 %)
stayed in hospital for < 5 days and 71 (30.5 %) stayed
for ≥ 5 days. More than half of the patients, 139
(59.7 %) had a single diagnosed disease. Of the
patients, more than half 128 (54.9 %) took 4–6 medi-
cations during hospitalization. Intravenous alone was
the most frequently used route of administration as
shown in Table 1.
The most common cause of MEs and ADEs was lack
of knowledge/information about the medication
accounting for 144 (61.8 %) of all cases (Table 2), which
was evidenced by inadequate knowledge of indications
about medication use, available dosage forms, appropriate
dosing, appropriate routes for administration and drug
compatibility in 53 (22.7 %), 3 (1.3 %), 83 (35.6 %), 8
(3.4 %) and 52 (22.3 %) cases, respectively. By drug class,
167 (71.7 %) patients encountered MEs and ADEs due to
antimicrobials, 44 (18.9 %) patients due to electrolytes and
fluids, 23 (9.9 %) patients due to analgesics with the
remainder due to other class of drugs.
The incidence of MEs per 100 orders, per 100 admis-
sions and per 100 patient days was 46.0, 220.2 and 51.4,
respectively. The incidence of potential ADEs per 100
orders, per 100 admissions, and per 100 patient days
was 6.7, 32.2 and 7.5, respectively. The incidence of
ADEs per 100 orders, per 100 admissions and per 100
patient days was 1.5, 7.3 and 1.7, respectively (Table 3).
Out of 233 patients, 175 (75.1 %) experienced at least
one error, whilst 93 (39.9 %) experienced 3 or more er-
rors. Overall, there were 513 MEs from 1115 medication
orders over the 999 patient days. There were 75 (32.2 %)
potential ADEs, of which 15 (20 %) were intercepted
while 60 (80 %) were not. Of the 175 (75.1 %) patients
who encountered MEs 8 (4.6 %) patients developed
ADEs. Overall, 17 (7.3 %) ADEs were identified, of which
8 (47 %) were preventable while 9 (53 %) were not. Out
of the 17 ADEs 9 were ADRs, according to the Naranjo
algorithm score, 1 (11 %) ADRs classified as “possible
ADRs” with a probability score of 1 to 4, and 8 (89 %)
events were defined as probable with a probability score
of 5 to 8. There is no ADR which is classified as definite
ADR (Table 4). Of the ADEs that occurred 13 (76.5 %)
necessitated discontinuation of the drug while 4 (23.5 %)
necessitated medication dosage change. All of the pa-
tients with ADRs recovered without sequelae (Table 4).
The most common MEs were dosing errors (118;
23 %), followed by wrong drug (109; 21.2 %), wrong time
(79; 15.4 %) and deteriorated drug (75; 14.6 %). The
most common stage at which MEs occurred was phys-
ician ordering 235 (45.8 %) (Table 5). Of the errors that
happened during physician ordering, 20 (8.5 %) were
intercepted before reaching the patient, of these 15
(75 %) were intercepted during transcription, while 5
(25 %) were intercepted during dispensing. Of the errors
that happened during transcription, 8 (66.7 %) were
intercepted before reaching the patient, of these 4
(50 %) were intercepted during dispensing, while 4
(50 %) were intercepted during administration. Of the
errors that happened during dispensing, 15 (71.4 %)
were intercepted before reaching the patient during
administration (Table 5).
Regarding severity of the MEs, of the errors encoun-
tered in the study using the more detailed scale pub-
lished by the NCC MERP, 7 (3 %) were classified as
Category A (circumstances or events that have the
capacity to cause error), 48 (20.6 %) were classified as
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Category B (an error occurred but the error did not
reach the patient) and 147 (63.1 %) were classified as
Category C (an error occurred that reached the patient
but did not cause patient harm).
Regarding severity of the ADEs, of the 17 ADEs 8
(47.1 %) were associated with error and using the more
detailed scale published by the NCC MERP, 7 (41.2 %)
were classified as Category E (an error occurred that re-
sulted in the need for treatment or intervention and
caused temporary patient harm) and 1 (5.9 %) were clas-
sified as Category F (an error occurred that resulted in
initial or prolonged hospitalization and caused tempor-
ary harm). None was associated with permanent harm,
or death.
The bivariable analysis showed that MEs were associ-
ated with length of hospital stay, number of disease condi-
tions, number of medications and route of administration.
However, other factors did not show statistically signifi-
cant association with MEs (Table 6).
Factors that were significantly associated with MEs at
p < 0.05 with multivariable analysis were length of
hospital stay and number of medication used per patient.
While dealing with these factors, patients who stayed in
the hospital for ≥ 5 days are almost 4 times more likely
to have MEs than patients who stayed in the hospital for
< 5 days (AOR = 4.2, 95 % CI = 1.7-10.4, p = 0.002).
Patients who have used 4–6 medications are almost 5
times more likely to have MEs than patients who have
used 1–3 medications (AOR = 4.9, 95 % CI = 2.3-10.3, p
< 0.001), similarly patients who used ≥7 medications are
almost 10 times more likely to have MEs than patients
who used 1–3 medications (AOR = 10.4, 95 % CI = 3.0-
35.9, p < 0.001) (Table 6).
The bivariable analysis showed that ADEs were associ-
ated with length of hospital stay and number of disease
conditions. However, other factors did not show a statis-
tically significant association with ADEs (Table 7).
Factors that were significantly associated with ADEs
using multivariable analysis were length of hospital stay
Table 1 Patient profiles and Medication related factors among hospitalized children in Nekemte Referral Hospital, West Ethiopia,
from February 24 to March 28, 2014 (n = 233)
Variables Categories Frequency Percent
Sex Female 84 36.1 %
Male 149 63.9 %
Age Category in days ≤28 (Neonates) 36 15.5 %
29-365 (Infants) 75 32.2 %
366-1095 (Toddlers) 43 18.5 %
1096-1825 (Preschoolers) 31 13.3 %
1826-3650 (School-aged children) 29 12.4 %
3651-5110 (Adolescents) 19 8.2 %
Length of hospital stay in days <5 162 69.5 %
≥5 71 30.5 %
Number of disease 1 139 59.7 %
2 79 33.9 %
≥3 15 6.4 %
Number of medication used per patient 1-3 63 27.0 %
4-6 128 54.9 %
≥7 42 18.0 %
Route of administration PO 42 18.0 %
IV 107 45.9 %
IV + PO 72 30.9 %
Others 12 5.2 %
PO Per Oral
IV Intravenous
Table 2 Health professional related factors related to MEs and
ADEs among hospitalized children in Nekemte Referral Hospital,
West Ethiopia, from February 24 to March 28, 2014 (n = 233)
Variables Frequency Percent
Lack of information about the patient 10 4.3 %
Lack of knowledge of the medication 144 61.8 %
Incomplete medication order processed 22 9.4 %
Patient identification not checked 1 0.4 %
Illegible physician handwriting 9 3.9 %
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and number of diseases. While dealing with these factors,
patients who stayed in the hospital for ≥ 5 days are 3.5
times more likely to have ADEs than patients who stayed
for < 5 days (AOR = 3.5, 95 % CI = 1.2-10.1, p = 0.023).
Patients who diagnosed with two concomitant diseases
are 4.6 times more likely to have ADEs than patients who
diagnosed with one disease (AOR = 4.6, 95 % CI = 1.4-
15.1, p = 0.014) (Table 7).
Discussions
In this prospective study, we found that 75.1 % of pa-
tients had been exposed to at least one ME and 39.9 %
of patients had 3 or more errors. Different strategies
should be used to decrease the high rate of medication
errors; development and implementation of a computer-
ized physician order entry (CPOE) system, ward-based
clinical pharmacists, avoidance of verbal orders, verbal
orders read back, medication reconciliation, double
check and patient (parent) active participation in care
[20]. Nearly comparable results were reported from
Jimma University Specialized Hospital Study, where
55.4 % of the patients experienced at least one medica-
tion error (Chanie et al. 2011, unpublished work). How-
ever, this result is nearly triple that of the study
conducted in USA, where 28.6 % of patients had at least
one ME and 5.7 % patients had 3 or more errors [5].
This difference might be due to the differences in the
hospital settings such as differences in training levels of
health care professionals, availability of support system
and composition of health care team and differences in
data collection methods, differences in the definitions of
terms and interpretations of the errors.
Pediatrics pose a unique set of risks of medication
errors, predominantly because of the need for dosage
calculations, which are individually based on the patient’s
weight, age or body surface area, and their condition. This
increases the likelihood of errors, particularly dosing
errors. For potent drugs, when only a small fraction of the
adult dose is required for children, it becomes very easy to
cause 10-fold or greater dosing errors because of miscal-
culation or misplacement of the decimal point [21]. The
present study finding showed that the most frequent MEs
were dosing errors 23 %, which is comparable with the
results of USA studies, 28 % and 28.4 % [5, 22]. Similar
results, 29.1 % were reported regarding dosing errors from
Jimma University Specialized Hospital Study (Chanie et al.
2011, unpublished work).
The medication process is significantly prone to errors,
especially during prescription and drug administration.
Implementation of medication error reduction strategies
is required in order to increase the safety and quality of
pediatric healthcare [23]. In this study, the most common
stage for MEs was physician ordering 45.8 %. However,
this finding is lower than the studies conducted in USA in
which physician ordering was found to be the most
common stage for errors, contributing to 74 % [5] and
77.8 % [22] of errors. These differences are probably due
to errors like no or wrong date on prescription paper,
missing or wrong weight were included in their study.
However, this finding is not similar with another study in
Table 3 Incidence of MEs and ADEs among hospitalized children in Nekemte Referral Hospital, West Ethiopia, from February 24 to
March 28, 2014 (n = 233)
Variables Total Number per 100 orders Number per 100 admissions Number per 100 patient days
Medication orders 1115 NA 478.5 111.6
Medication errors 513 46.0 220.2 51.4
Potential ADEs 75 6.7 32.2 7.5
ADEs 17 1.5 7.3 1.7
ADRs 9 0.8 3.8 0.9
NA Not applicable
Table 4 MEs, Potential ADEs and ADEs among hospitalized
children in Nekemte Referral Hospital, West Ethiopia, from
February 24 to March 28, 2014 (n = 233)
Variables Categories Frequency Percent
Patients with a ME No 58 24.9 %
Yes 175 75.1 %
Number of MEs per patient 0 58 24.9 %
1 35 15.0 %
2 47 20.2 %
≥3 93 39.9 %
Patient with a potential ADE No 158 67.8 %
Yes 75 32.2 %
Potential ADE intercepted No 60 80 %
Yes 15 20 %
ADE occurred No 216 92.7 %
Yes 17 7.3 %
ADR occurred No 224 96.1 %
Definite 0 -
Probable 8 3.4 %
Possible 1 0.4 %
Category of ADE Preventable 8 47 %
Non-preventable 9 53 %
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USA [4] and Jimma University Specialized Hospital Study
(Chanie et al. 2011, unpublished work) that reported
administration errors accounting for 51 % and 54.3 % of
detected errors, respectively was the most common stage
of errors. The difference might be due to differences in
the types of medication errors that the study included.
In this study, the length of hospital stay was signifi-
cantly associated (P = 0.001) with MEs and it was one of
the independent predictors of MEs. The present finding
is consistent with that reported by other studies from
Jimma University Specialized Hospital (Chanie et al.
2011, unpublished work) and USA [24, 25]. This is be-
cause as the patient hospital stay is prolonged the pa-
tient will be exposed to a number of administrations of
medication and this may lead to the occurrence of MEs.
As the number of disease conditions increased there
could be increased medication prescription that is
required for the treatment of the disease conditions and
this may lead to the occurrence of MEs. The present
study showed that the number of diseases a child had
was significantly associated (P = 0.012) with MEs in
bivariable analysis, but generally number of diseases was
not independent predictor of MEs in multivariable
analysis (P > 0.05). However, a study done in USA by
Ahuja et al. showed that there was a statistically signifi-
cant association between the number of disease condi-
tions and MEs in multivariable analysis [25].
The more medications a patient is consuming, the more
likely for the occurrence of MEs. The present study
showed that the number of medications used by the
patient was significantly associated (P < 0.001) with MEs
and it was one of the independent predictors of MEs. This
is in-line with the study from Jimma University Special-
ized Hospital (Chanie et al. 2011, unpublished work).
In this study, the route of administration had a signifi-
cantly associated difference for intravenous administra-
tion (P = 0.003) with oral route of administration, which
was considered as reference in bivariable analysis, but
generally route of administration was not shown to be a
predictor of MEs in multivariable analysis (P > 0.05). The
Table 5 Type of MEs and stages at which error occurred
among hospitalized children in Nekemte Referral Hospital, West




Wrong drug 109 21.2 %
Wrong patient 1 0.2 %
Wrong dose 118 23 %
Wrong dosing schedule 9 1.8 %
Wrong route 12 2.3 %
Wrong time 79 15.4 %
Deteriorated drug 75 14.6 %
Omission 21 4.1 %
Wrong dosage form 6 1.2 %
Non-adherence 23 4.5 %




Stage of error Physician ordering 235 45.8 %
Transcribing 12 2.3 %
Dispensing pharmacist 21 4.1 %
Nurse administering 179 34.9 %
Patient monitoring 43 8.4 %
Otherb 23 4.5 %
a Medication errors that does not fall into one of above categories
bMedication errors that happen due to patient non-adherence
Table 6 Bivariable and Multivariable analysis of factors associated with MEs among hospitalized children in Nekemte Referral
Hospital, Western Ethiopia, from February 24 to March 28, 2014
Variables Categories COR (95 % CI) P value AOR (95 % CI) P value
Length of hospital stay in days <5 1.00 1.00
≥5 4.20(1.80-9.81) P = 0.001 4.24(1.73-10.40) P = 0.002
Number of disease 1 1.00
2 2.50(1.23-5.10) P = 0.012 —
≥3 1.79(0.48-6.68) P = 0.385 —
Number of medication used per patient 1-3 1.00 1.00
4-6 4.974(2.53-9.76) P = 0.000 4.90(2.33-10.32) P = 0.000
≥7 9.806(3.13-30.74) P = 0.000 10.39(3.01-35.92) P = 0.000
Route of administration PO 1.00 1.00
IV 3.36(1.51-7.47) P = 0.003 2.12(0.87-5.15) P = 0.099
IV + PO 2.20(0.97-5.00) P = 0.060 0.93(0.35-2.45) P = 0.877
Others 0.68(0.19-2.47) P = 0.557 0.54(0.12-2.40) P = 0.416
COR Crude odds ratio
AOR Adjusted odds ratio
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present finding is consistent with the report from Jimma
University Specialized Hospital Study [8], USA [5] and
Saudi Arabia [26]. However, it is not consistent with a
study done in Dessie Hospital which reported that the
intravenous route was less likely to be associated with pre-
scribing errors [27]. The probable reason is that the study
done in Dessie Hospital studied only prescription errors.
Pediatric patients are vulnerable to ADEs because drugs
are less likely have been studied extensively in these age
groups, and drug absorption and metabolism are more
variable and less predictable in these groups. In this pro-
spective study, we found that 7.3 % of patients who were
seen in pediatrics ward have been exposed to ADEs; of
these 47 % were preventable, while 53 % were not. The re-
sult of this study is comparable to a study done in Jimma
University Specialized Hospital (Chanie et al. 2011, un-
published work) in which 9.2 % of patients were subjected
to ADEs, with 32.7 % classified as preventable and a study
in China [28] which identified 6 % of patients were ex-
posed to ADEs of which 61 % classified as preventable.
However, the results are higher than a study done in USA
which identified 2.3 % of patients suffered ADEs of which
19 % were classified as preventable [5]. The possible rea-
sons for the difference might be due to differences in the
methods of detection as this study used the pediatrics trig-
ger toolkit to efficiently identify ADEs.
Regarding the ADRs this study found a higher incidence
of ADRs (3.8 per 100 admissions) than the studies done in
Italy, 0.9 % [29] and France, 2.64 % [30]; and a lower inci-
dence than the studies done in Germany, 31.8 % [31],
Saudi Arabia, 8.2 % [32] and Brazil, 12.5 % [33]. The pos-
sible reasons for the differences might be due to differ-
ences in the length of hospital stay of patients and also
methods used to detect events. The present study was
done on a small number of patients and short study dur-
ation which could be the additional reasons.
In this study, the length of hospital stay was signifi-
cantly associated with ADEs and it was one of the inde-
pendent predictors of ADEs. The present finding is
consistent with that reported by other studies from
China [28], Jimma University Specialized Hospital Study
(Chanie et al. 2011, unpublished work) and Brazil [33].
Multiple diseases make patients more vulnerable to
ADEs due to the presence of many diseases and the use
of many drugs. The finding of this specific research
showed that patients who diagnosed with two diseases
are almost 4 times more likely to have ADEs than
patients who diagnosed with one disease. This finding is
similar to a prospective study done in china [28].
Regarding the number of medications used per patient,
the more the medications that are prescribed for a par-
ticular patient the greater the risk of ADEs. Studies from
China [28] and Brazil [34] have shown that the number
of medications used by the patient is significantly associ-
ated with ADEs; but this study showed no significant
deference between taking higher and lower number of
medications. This may be due to the short duration of
study period and patients’ short length of hospital stay
as indicated in the result which might underestimate de-
tection of ADEs. The present finding is similar to a
study done in Jimma University Specialized Hospital
(Chanie et al. 2011, unpublished work).
This study has some strengths and limitations. The
strength of this study was being a prospective observa-
tional study, in which patients were followed from the
date of admission to the date of discharge/transfer/
death. We used a multidisciplinary approach that exam-
ined all aspects of the medication delivery process, from
the physician’s order through administration of the drug
to the patient and clinical progress.
Despite a comprehensive multidisciplinary approach to
data collection, we probably failed to detect some errors,
particularly administration errors detected more reliably
by trained observers following nurses during routine pa-
tient care activities [5]. Because nurses and physicians
on the study wards were aware of the study, the Haw-
thorne effect could have affected both the occurrence
and detection of errors. The incidence of errors could
have been reduced as the study progressed because we
were obliged to take corrective action when we identi-
fied serious practice problems. Other limitations were
that only two health professionals were involved for
assessing severity and preventability which might affect
the classification of the event; it is a single ward, single
Table 7 Bivariable and multivariable analysis of factors associated with ADEs among hospitalized children in Nekemte Referral
Hospital, Western Ethiopia, from February 24 to March 28, 2014
Variables Categories COR (95 % CI) P value AOR (95 % CI) P value
Length of hospital stay in days <5 1.00 1.00
≥5 4.77(1.69-13.46) P = 0.003 3.46(1.18-10.13) P = 0.023
Number of disease 1 1.00 1.00
2 6.05(1.88-19.45) P = 0.003 4.55(1.37-15.12) P = 0.014
≥3 2.41(0.25-23.09) P = 0.445 2.06(0.21-20.31) P = 0.537
COR Crude odds ratio
AOR Adjusted odds ratio
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hospital study and therefore might not be generalized to
other hospitals in Ethiopia. Small study size and short
duration of study were also limitations of this study.
Conclusions
Generally, the results of this study suggest that MEs,
potential ADEs and actual ADEs are common in the
Nekemte Referral Hospital’s pediatrics ward. Multivari-
able logistic regression analysis outputs showed that
length of hospital stay and the number of medication
the patient took were independent predictors of medica-
tion errors. Similarly, length of hospital stay and number
of disease conditions were independent predictors of
ADEs. Hence, every error should be examined to deter-
mine what elements in the medication delivery process
allowed it to happen. In this way, those who manage
health systems can learn from error and determine what
corrections are needed to prevent similar errors in the
future.
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